AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Diagnostics companies at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
40 diagnostics companies are at AMP 2026 — 36 presentations on the program and 36 with a booth in the exhibit hall. Most represented: Natera (3 on the program), Roche Diagnostics (3 on the program), Foundation Medicine (2 on the program). 24 of them have their own page in this guide. As of Nov 12, 2026.
Program track
Top represented
Showing 1–14 of 40 organizations
| Organization | AMP 2026 Attendance |
|---|---|
Natera San Carlos, CA | |
Cell-free DNA testing company; Signatera is a custom ctDNA test for molecular residual disease assessment and treatment monitoring. | Booth Exhibiting at Booth 445 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 4:00pm–4:50pm Title: Advancements in MRD Testing: The Expanding Role of Digital Pathology and AI Digital pathology and machine learning applied to specimen assessment and interpretation in residual disease testing. Poster Thu, Nov 12 2:45pm–3:00pm |
Roche Diagnostics Indianapolis, IN | |
Clinical diagnostics, life science research, digital PCR and next-generation sequencing systems and assays for laboratories. | Booth Exhibiting at Booth 700 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Diamond Partner Workshop Wed, Nov 11 10:00am–10:50am Unlocking the Complete Lyo-Ready Workflow: From Sample Preparation to Amplification A shelf-stable reagent set spanning sample prep, reverse transcription and amplification for assays built without cold-chain storage. Workshop Wed, Nov 11 11:00am–11:50am Automated and Integrated Genomic Profiling of Hematologic Malignancies Sequencing workflows for blood cancers that report mutations, structural variants and clonal evolution in one automated run. Workshop Wed, Nov 11 12:00pm–12:50pm Next-Generation Sequencing with Roche’s AXELIOS 1 Platform Roche's AXELIOS 1 sequencer and its expansion-based chemistry, covering accuracy, read length and run flexibility. Workshop Wed, Nov 11 1:00pm–1:50pm Versatile Whole-exome Sequencing Enables End-to-end Phenotype-driven DNA-variant identification or RNA-fusion detection Phenotype-driven exome workflows for germline variant discovery, plus two RNA-sequencing routes to fusions. Workshop Wed, Nov 11 9:00am–9:50am Advancing HLA Class I Typing Through Comprehensive Genomic Profiling Adding HLA class I typing to comprehensive genomic profiling, with immuno-oncology uses from checkpoint inhibitors to cell therapy. |
Foundation Medicine Boston, MA | |
Molecular information company providing comprehensive genomic profiling to inform cancer treatment decisions. | Booth Exhibiting at Booth 1701, MR14 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am Molecular Residual Disease in Breast Cancer: Advancing Surveillance and Clinical Decision-Making Tissue-informed circulating tumor DNA testing in breast cancer, from baseline through surveillance and early recurrence detection. Workshop Wed, Nov 11 9:00am–9:50am Advancing HLA Class I Typing Through Comprehensive Genomic Profiling Adding HLA class I typing to comprehensive genomic profiling, with immuno-oncology uses from checkpoint inhibitors to cell therapy. Talk Thu, Nov 12 7:15am–8:15am Adapting Communication Strategies for Today's Pathology Learners (A Special EdCoP Event) Teaching pathology trainees across generations and learning styles, including feedback and handling performance problems. |
Guardant Health Palo Alto, CA | |
Precision oncology company offering blood and tissue tests, real-world data and AI analytics for cancer care. | Booth Exhibiting at Booth 1043 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 2:00pm–2:50pm Building Scalable Clinical Genomics Workflows: Practical Lessons from Leading Laboratories Scaling sequencing operations in molecular labs, plus how to keep trust in AI-assisted variant interpretation. |
Arima Genomics Carlsbad, CA | |
Cancer diagnostics from whole-genome sequence and structure; runs the CLIA-certified Aventa clinical lab and supplies research kits and informatics. | Booth Exhibiting at Booth 536 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 2:00pm–2:50pm Aventa Clinical Testing Powered by Arima Hi-C: Revealing Actionable Genomic Structure Across Lymphoma, Lung Cancer, and Sarcoma Hi-C sequencing of FFPE tissue to map fusions and rearrangements in lymphoma, lung cancer and sarcoma cases. |
Biocartis Mechelen, Belgium | |
Idylla platform delivering in-house molecular biomarker results in about three hours, with diagnostic tests and research assays across several cancers. | Booth Exhibiting at Booth 623 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am Decentralized Precision Testing: AI, Gene Signatures, and Rapid Biomarker Testing in Real-World Settings Rapid biomarker testing and AI tools deployed in community health systems alongside academic cancer centres. |
Geneseeq Technology Toronto, Canada | |
Next-generation sequencing for cancer care: comprehensive genomic profiling, cancer panels, minimal residual disease monitoring and multi-cancer early detection. | Booth Exhibiting at Booth 1919 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 3:00pm–3:50pm Machine Learning–Driven Drug Discovery and Precision Oncology Powered by DNBSEQ-T1+ Sequencing Users of DNBSEQ-T1+ sequencing describe large protein–small molecule screens for drug discovery and validation of cancer genomic profiling panels. |
Inocras San Diego, CA | |
Whole-genome sequencing and AI-driven bioinformatics for cancer and rare disease, offering clinical testing and research data integration. | Booth Exhibiting at Booth 2305 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm |
MRC Holland Amsterdam, Netherlands | |
Assays for gene copy number and methylation detection, including MLPA and digitalMLPA probemixes for hereditary disorders and tumour profiling. | Booth Exhibiting at Booth 643 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm |
CAP and CLIA certified laboratory offering cell-free DNA and RNA liquid biopsy testing for cancer. | Workshop Wed, Nov 11 1:00pm–1:50pm Advancing Cell-Free Nucleic Acid Testing: Integrated Workflows for Prenatal and Oncology Applications Cell-free DNA and RNA workflows for prenatal screening and oncology, including why DNA-only sequencing misses actionable fusions. |
Labcorp's cancer genomic profiling business, formerly Personal Genome Diagnostics, selling kitted tumor-profiling tests that laboratories run in-house. | Workshop Wed, Nov 11 9:00am–9:50am Streamlined Comprehensive Genomic Profiling on Clear Dx: Automated Extraction and Library Prep on One Platform Automating extraction and library prep for a tumor profiling panel, compared with the manual workflow on clinical FFPE specimens. |
Predicta Biosciences Cambridge, MA | |
Blood-cancer diagnostics company whose genome sequencing test on blood or bone marrow diagnoses and guides treatment of multiple myeloma. | Workshop Wed, Nov 11 12:00pm–12:50pm Next-Generation Sequencing with Roche’s AXELIOS 1 Platform Roche's AXELIOS 1 sequencer and its expansion-based chemistry, covering accuracy, read length and run flexibility. |
Univ8 Genomics Belfast, UK | |
Makes targeted NGS assays for leukaemia, lymphoma and myeloid cancers that detect clonality, translocations, copy number changes and mutations in one test. | Workshop Wed, Nov 11 11:00am–11:50am Automated and Integrated Genomic Profiling of Hematologic Malignancies Sequencing workflows for blood cancers that report mutations, structural variants and clonal evolution in one automated run. |
Bio-Techne Diagnostics Austin, TX | |
Supplies clinical labs and assay developers with amplification-based enrichment and long-read sequencing products for genetic and oncology testing. | Booth Exhibiting at Booth 737, 837 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 11:00am–11:50am Deep Sensitivity Meets Workflow Efficiency: Optimizing HemOnc MRD Testing in Your Laboratory Quantitative PCR for myeloid residual disease, including laboratory experience validating a new PML-RARA kit and its workflow. |
Find buyers from diagnostics companies
Tell us what you sell and we’ll find the people at these diagnostics companies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse AMP 2026 by
Organization type
Program track
Exhibit hall
Everyone
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction